Intellectual Property

Patent rights in the U.S., Europe, Japan, Australia, Canada, Singapore, China, India, Hong Kong and Brazil
• 27 issued patents
• 27 pending applications

Patent portfolio of (7) patent families including:
• BPZE strains
• BPZE vaccines for the prevention of Whooping Cough
• Influenza Cross-protection
• Asthma and Allergy treatment/prophylaxis
• New BPZE1 strains

Country

Name

Patent No.

Date Issued

U.S.

• Attenuated Bordetella strains

9,730,995

Aug 15, 2017

Australia

• Effect of an attenuated Bordetella strain against allergic disease

61/554,798

July 13, 2017

U.S.

• Adenylate cyclase deficient bordetella strains

9,655,959

May 23, 2017

U.S.

• Influenza vaccine, composition, and methods of use

9,526,778

Dec. 27, 2016

U.S.

• Recombinant Bordetella Strains

9,528,086

Dec. 27, 2016

Japan

• Vaccine for prophylaxis or treatment of an allergen-driven airway pathology

2014-105874

Sept. 2 2016

U.S.

• Method of using attenuated Bordetella strains

9,180,178

Nov. 10 2015

U.S.

• Live attenuated Bordetella strains as a single dose vaccine against whooping cough

9,119,806

Sept. 1 2015

Canada

• Influenza vaccine, composition, and methods of use

2,765,364

May 26, 2015

U.S.

• Vaccine for prophylaxis or treatment of an allergen-driven airway pathology

8,986,709

Mar. 24, 2015

Japan

• Vaccine for prophylaxis or treatment of an allergen-driven airway pathology

2012-567803

Jan. 1, 2015

Japan

• Live attenuated Bordetella strains as a single dose vaccine against whooping cough

2012-5151774

May 30, 2014

Europe

• Live attenuated Bordetella strains as a single dose vaccine against whooping cough

1994139

Jul. 7, 2013

Japan

• Influenza vaccine, composition, and methods of use

2013-524092

Apr. 4, 2013

Australia

• Live attenuated Bordetella strains as a single dose vaccine against whooping cough

2007224734

Mar. 20, 2013

China

• Method of using attenuated Bordetella strains

CN101400783B

Mar. 3 2013

Japan

• Method of using attenuated Bordetella strains

2012-530128

Nov. 29 2012

Canada

• Influenza vaccine, composition, and methods of use

2765364

Dec. 23, 2010

Europe

• Vaccine for prophylaxis or treatment of an allergen-driven airway pathology

PCT/EP2010/055507

Apr. 26, 2010

Japan

• Vaccine for prophylaxis or treatment of an allergen-driven airway pathology

2012-507703

Apr. 26, 2010

Singapore

• Vaccine for prophylaxis or treatment of an allergen-driven airway pathology

2011078771

Apr. 26, 2010

Austrailia

• Influenza vaccine, composition, and methods of use

2009348207

Jun. 15, 2009

Europe

• Influenza vaccine, composition, and methods of use

PCT/IB2009/007153

Jun. 15 2009

Australia

• Vaccine for prophylaxis or treatment of an allergen-driven airway pathology

2010243708

Apr. 28, 2009

China

• Live attenuated Bordetella strains as a single dose vaccine against whooping cough

ZL2009801609531

Sept. 20, 2007

India

• Live attenuated Bordetella strains as a single dose vaccine against whooping cough

270798

Mar. 7, 2007

France

• Method of using attenuated Bordetella strains

2840319

Dec. 5, 2003


Copyright 2013-2017 ILiAD Biotechnologies